top of page


Biocompatibility Testing for Wearable Medical Devices: What ISO 10993-1:2025 Requires
Wearable medical devices — continuous glucose monitors, cardiac monitoring patches, drug delivery wearables, diagnostic biosensors — are regulated medical devices. That means before they reach patients, they go through biological evaluation under ISO 10993-1:2025. For manufacturers new to the biocompatibility process, the question is usually: what does that actually require? The answer depends on your specific device — its materials, its patient contact, how long it stays on

JL Tox Consulting
Oct 145 min read


Chemical Characterization vs Biological Testing: When Each is Required for Medical Devices
Medical device biocompatibility evaluation involves two distinct but complementary approaches: chemical characterization and biological testing. Understanding when each is required—and how they work together—is essential for efficient regulatory submissions and comprehensive safety evaluation. Many manufacturers struggle with determining the appropriate balance between these approaches. Over-reliance on biological testing can miss critical chemical safety concerns, while foc

JL Tox Consulting
Dec 11, 20259 min read
bottom of page